News

The Mexican Soluble Ferric Pyrophosphate (SFP) patent grant covers the method and pharmaceutical composition for iron delivery administered in hemodialysis and peritoneal dialysis patients. Based on previous FDA

The LifeStent self-expanding nitinol stent is a percutaneously-delivered flexible mesh tube that expands when deployed to prop open a diseased vessel and is specifically designed to withstand bending

As per the agreement, the combined expertise of the two companies creates a highly efficient product flow from API manufacturing through regulatory approval and distribution that will bring

Mr Sidransky is a renowned oncologist and research scientist named and profiled by TIME magazine in 2001 as one of the top physicians and scientists in America, recognized

Under the terms of the agreement, Asuragen will receive an undisclosed payment for the development of the test that is expected to be completed in 2008. Upon completion

Cleviprex is a novel investigational IV antihypertensive for the treatment of acute hypertension when the use of oral therapy is not feasible or desirable. Among patients treated in

In the study, trodusquemine was found to be well-tolerated at likely clinical doses, and no serious adverse events were seen in healthy overweight and obese adults. Study MSI-1436C-101,

Consistent with the anti-VEGFR activity of XL184, preliminary pharmacodynamic analyses show reductions in several biomarkers of angiogenesis. Anti-tumor activity has been observed in a variety of cancers at

Hana Biosciences’ data has demonstrated anti-tumor activity in three of eleven patients with refractory solid tumors and has also showed that Alocrest was relatively well tolerated over multiple